Equities research analysts predict that Medical Properties Trust (NYSE:MPW) will post $0.36 earnings per share (EPS) for the current fiscal quarter, Zacks reports. Six analysts have provided estimates for Medical Properties Trust’s earnings, with the lowest EPS estimate coming in at $0.34 and the highest estimate coming in at $0.38. Medical Properties Trust posted earnings per share of $0.33 in the same quarter last year, which would suggest a positive year-over-year growth rate of 9.1%. The company is expected to report its next earnings report on Thursday, May 3rd.
According to Zacks, analysts expect that Medical Properties Trust will report full year earnings of $1.43 per share for the current fiscal year, with EPS estimates ranging from $1.39 to $1.46. For the next financial year, analysts forecast that the business will report earnings of $1.46 per share, with EPS estimates ranging from $1.41 to $1.50. Zacks’ earnings per share calculations are an average based on a survey of analysts that that provide coverage for Medical Properties Trust.
Medical Properties Trust (NYSE:MPW) last issued its quarterly earnings data on Thursday, February 8th. The real estate investment trust reported $0.37 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.02. The business had revenue of $205.00 million for the quarter, compared to analyst estimates of $204.52 million. Medical Properties Trust had a return on equity of 7.85% and a net margin of 41.12%. Medical Properties Trust’s quarterly revenue was up 33.7% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.31 EPS.
A number of equities research analysts recently weighed in on MPW shares. ValuEngine lowered Medical Properties Trust from a “buy” rating to a “hold” rating in a research report on Monday, April 2nd. Deutsche Bank reduced their price objective on Medical Properties Trust from $13.50 to $13.00 and set a “hold” rating on the stock in a research report on Monday, March 19th. Zacks Investment Research upgraded Medical Properties Trust from a “sell” rating to a “hold” rating in a research report on Tuesday, January 16th. Finally, Robert W. Baird lowered Medical Properties Trust from an “outperform” rating to a “neutral” rating and reduced their price target for the company from $15.00 to $13.00 in a research report on Friday, January 5th. One equities research analyst has rated the stock with a sell rating, seven have given a hold rating and four have assigned a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $14.28.
In other Medical Properties Trust news, Chairman Edward K. Aldag, Jr. sold 489,971 shares of the company’s stock in a transaction dated Thursday, February 15th. The stock was sold at an average price of $12.39, for a total value of $6,070,740.69. Following the sale, the chairman now owns 2,192,629 shares in the company, valued at approximately $27,166,673.31. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, Chairman Edward K. Aldag, Jr. sold 116,216 shares of the company’s stock in a transaction dated Tuesday, March 27th. The shares were sold at an average price of $12.56, for a total value of $1,459,672.96. Following the completion of the sale, the chairman now owns 1,759,620 shares in the company, valued at approximately $22,100,827.20. The disclosure for this sale can be found here. Insiders own 1.00% of the company’s stock.
Institutional investors have recently made changes to their positions in the stock. Cottage Street Advisors LLC boosted its position in shares of Medical Properties Trust by 30.1% during the 4th quarter. Cottage Street Advisors LLC now owns 106,800 shares of the real estate investment trust’s stock valued at $1,471,000 after purchasing an additional 24,700 shares in the last quarter. LSV Asset Management boosted its position in shares of Medical Properties Trust by 46.9% during the 4th quarter. LSV Asset Management now owns 8,788,100 shares of the real estate investment trust’s stock valued at $121,100,000 after purchasing an additional 2,805,124 shares in the last quarter. MetLife Investment Advisors LLC bought a new stake in shares of Medical Properties Trust during the 4th quarter valued at about $3,175,000. Claraphi Advisory Network LLC bought a new stake in shares of Medical Properties Trust during the 4th quarter valued at about $1,276,000. Finally, Parametrica Management Ltd bought a new stake in shares of Medical Properties Trust during the 4th quarter valued at about $267,000. Institutional investors own 80.92% of the company’s stock.
Shares of MPW stock opened at $12.44 on Monday. The firm has a market cap of $4,536.81, a P/E ratio of 9.21, a PEG ratio of 2.51 and a beta of 0.68. Medical Properties Trust has a twelve month low of $11.82 and a twelve month high of $14.19. The company has a debt-to-equity ratio of 1.28, a quick ratio of 2.06 and a current ratio of 2.06.
The business also recently declared a quarterly dividend, which was paid on Thursday, April 12th. Shareholders of record on Thursday, March 15th were given a $0.25 dividend. This represents a $1.00 dividend on an annualized basis and a dividend yield of 8.04%. The ex-dividend date of this dividend was Wednesday, March 14th. This is a positive change from Medical Properties Trust’s previous quarterly dividend of $0.24. Medical Properties Trust’s payout ratio is 74.07%.
WARNING: “Brokerages Expect Medical Properties Trust (MPW) to Post $0.36 EPS” was first reported by Dispatch Tribunal and is the sole property of of Dispatch Tribunal. If you are reading this report on another domain, it was illegally copied and reposted in violation of international trademark and copyright laws. The correct version of this report can be read at https://www.dispatchtribunal.com/2018/04/23/brokerages-expect-medical-properties-trust-mpw-to-post-0-36-eps.html.
Medical Properties Trust Company Profile
Medical Properties Trust, Inc is a self-advised real estate investment trust formed to capitalize on the changing trends in healthcare delivery by acquiring and developing net-leased healthcare facilities. MPT's financing model helps facilitate acquisitions and recapitalizations and allows operators of hospitals and other healthcare facilities to unlock the value of their real estate assets to fund facility improvements, technology upgrades and other investments in operations.
Get a free copy of the Zacks research report on Medical Properties Trust (MPW)
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Medical Properties Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medical Properties Trust and related companies with MarketBeat.com's FREE daily email newsletter.